25 XP   0   0   10

Achieve Life Sciences Inc
Buy, Hold or Sell?

Let's analyse Achieve Life Sciences Inc together

PenkeI guess you are interested in Achieve Life Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Achieve Life Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Achieve Life Sciences Inc

I send you an email if I find something interesting about Achieve Life Sciences Inc.

Quick analysis of Achieve Life Sciences Inc (30 sec.)










What can you expect buying and holding a share of Achieve Life Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.04
Expected worth in 1 year
$-0.33
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.28
Return On Investment
-6.3%

For what price can you sell your share?

Current Price per Share
$4.50
Expected price per share
$3.82 - $4.814
How sure are you?
50%

1. Valuation of Achieve Life Sciences Inc (5 min.)




Live pricePrice per Share (EOD)

$4.50

Intrinsic Value Per Share

$-9.27 - $-3.38

Total Value Per Share

$-9.31 - $-3.43

2. Growth of Achieve Life Sciences Inc (5 min.)




Is Achieve Life Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.4m$10.9m-$7.8m-245.2%

How much money is Achieve Life Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7.5m-$10.8m$3.2m42.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Achieve Life Sciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#887 / 1010

Most Revenue
#900 / 1010

Most Profit
#511 / 1010

Most Efficient
#356 / 1010

What can you expect buying and holding a share of Achieve Life Sciences Inc? (5 min.)

Welcome investor! Achieve Life Sciences Inc's management wants to use your money to grow the business. In return you get a share of Achieve Life Sciences Inc.

What can you expect buying and holding a share of Achieve Life Sciences Inc?

First you should know what it really means to hold a share of Achieve Life Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Achieve Life Sciences Inc is $4.5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Achieve Life Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Achieve Life Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.04. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Achieve Life Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.16-3.6%-0.22-4.8%-0.31-6.9%-0.20-4.4%-0.16-3.6%
Usd Book Value Change Per Share-0.16-3.6%-0.07-1.6%-0.14-3.2%-0.03-0.6%-0.03-0.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.16-3.6%-0.07-1.6%-0.14-3.2%-0.03-0.6%-0.03-0.6%
Usd Price Per Share4.12-5.10-4.55-5.00-3.62-
Price to Earnings Ratio-6.44--5.87--4.15--6.49--5.06-
Price-to-Total Gains Ratio-25.72--15.54--14.30--10.13--12.52-
Price to Book Ratio-97.46-120.78-35.79-35.50-19.61-
Price-to-Total Gains Ratio-25.72--15.54--14.30--10.13--12.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.5
Number of shares222
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.07-0.03
Usd Total Gains Per Share-0.07-0.03
Gains per Quarter (222 shares)-15.80-5.59
Gains per Year (222 shares)-63.20-22.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-63-730-22-32
20-126-1360-45-54
30-190-1990-67-76
40-253-2620-89-98
50-316-3250-112-120
60-379-3880-134-142
70-442-4510-157-164
80-506-5140-179-186
90-569-5770-201-208
100-632-6400-224-230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%19.094.00.016.8%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%11.029.00.027.5%37.076.00.032.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0113.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%11.029.00.027.5%37.076.00.032.7%

Fundamentals of Achieve Life Sciences Inc

About Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Fundamental data was last updated by Penke on 2024-04-10 23:27:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Achieve Life Sciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Achieve Life Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Achieve Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-40.8%+40.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y-40.8%-605.5%+564.7%
1.1.2. Return on Assets

Shows how efficient Achieve Life Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • -28.3% Return on Assets means that Achieve Life Sciences Inc generated $-0.28 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Achieve Life Sciences Inc:

  • The MRQ is -28.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -33.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.3%TTM-33.0%+4.7%
TTM-33.0%YOY-36.3%+3.3%
TTM-33.0%5Y-26.7%-6.3%
5Y-26.7%10Y-22.1%-4.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.3%-13.3%-15.0%
TTM-33.0%-12.8%-20.2%
YOY-36.3%-11.7%-24.6%
5Y-26.7%-13.9%-12.8%
10Y-22.1%-15.7%-6.4%
1.1.3. Return on Equity

Shows how efficient Achieve Life Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Achieve Life Sciences Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Achieve Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-605.0%+605.0%
TTM-605.0%YOY-387.6%-217.4%
TTM-605.0%5Y-214.6%-390.5%
5Y-214.6%10Y-119.3%-95.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM-605.0%-16.1%-588.9%
YOY-387.6%-15.1%-372.5%
5Y-214.6%-19.3%-195.3%
10Y-119.3%-20.2%-99.1%

1.2. Operating Efficiency of Achieve Life Sciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Achieve Life Sciences Inc is operating .

  • Measures how much profit Achieve Life Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Achieve Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-42.6%+42.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y-42.6%-632.4%+589.8%
1.2.2. Operating Ratio

Measures how efficient Achieve Life Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.672-0.672
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y0.6727.876-7.204

1.3. Liquidity of Achieve Life Sciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Achieve Life Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.82 means the company has $0.82 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 0.816. The company is just not able to pay all its short-term debts. -1
  • The TTM is 3.690. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ0.816TTM3.690-2.874
TTM3.690YOY5.684-1.994
TTM3.6905Y6.603-2.914
5Y6.60310Y5.146+1.457
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8163.890-3.074
TTM3.6904.173-0.483
YOY5.6845.344+0.340
5Y6.6036.126+0.477
10Y5.1466.448-1.302
1.3.2. Quick Ratio

Measures if Achieve Life Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.75 means the company can pay off $0.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 0.752. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 3.458. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.752TTM3.458-2.706
TTM3.458YOY5.439-1.980
TTM3.4585Y6.352-2.893
5Y6.35210Y5.302+1.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7523.514-2.762
TTM3.4583.998-0.540
YOY5.4395.380+0.059
5Y6.3526.105+0.247
10Y5.3026.404-1.102

1.4. Solvency of Achieve Life Sciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Achieve Life Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Achieve Life Sciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.07 means that Achieve Life Sciences Inc assets are financed with 107.5% credit (debt) and the remaining percentage (100% - 107.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 1.075. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.888. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.075TTM0.888+0.187
TTM0.888YOY0.691+0.197
TTM0.8885Y0.417+0.471
5Y0.41710Y0.357+0.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0750.339+0.736
TTM0.8880.336+0.552
YOY0.6910.271+0.420
5Y0.4170.366+0.051
10Y0.3570.389-0.032
1.4.2. Debt to Equity Ratio

Measures if Achieve Life Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM13.239-13.239
TTM13.239YOY6.702+6.537
TTM13.2395Y4.123+9.116
5Y4.12310Y2.298+1.826
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.388-0.388
TTM13.2390.402+12.837
YOY6.7020.335+6.367
5Y4.1230.426+3.697
10Y2.2980.461+1.837

2. Market Valuation of Achieve Life Sciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Achieve Life Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • A PE ratio of -6.44 means the investor is paying $-6.44 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Achieve Life Sciences Inc:

  • The EOD is -7.037. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.443. Based on the earnings, the company is expensive. -2
  • The TTM is -5.873. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.037MRQ-6.443-0.594
MRQ-6.443TTM-5.873-0.569
TTM-5.873YOY-4.145-1.728
TTM-5.8735Y-6.491+0.618
5Y-6.49110Y-5.060-1.431
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.037-2.264-4.773
MRQ-6.443-2.629-3.814
TTM-5.873-2.680-3.193
YOY-4.145-4.1450.000
5Y-6.491-6.257-0.234
10Y-5.060-6.254+1.194
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Achieve Life Sciences Inc:

  • The EOD is -8.818. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.073. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.223. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.818MRQ-8.073-0.745
MRQ-8.073TTM-7.223-0.850
TTM-7.223YOY-4.742-2.481
TTM-7.2235Y-7.773+0.550
5Y-7.77310Y-6.907-0.866
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.818-2.973-5.845
MRQ-8.073-3.333-4.740
TTM-7.223-3.553-3.670
YOY-4.742-5.605+0.863
5Y-7.773-8.376+0.603
10Y-6.907-8.865+1.958
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Achieve Life Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -97.46 means the investor is paying $-97.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Achieve Life Sciences Inc:

  • The EOD is -106.446. Based on the equity, the company is expensive. -2
  • The MRQ is -97.457. Based on the equity, the company is expensive. -2
  • The TTM is 120.777. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-106.446MRQ-97.457-8.989
MRQ-97.457TTM120.777-218.234
TTM120.777YOY35.792+84.985
TTM120.7775Y35.497+85.280
5Y35.49710Y19.608+15.888
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-106.4461.896-108.342
MRQ-97.4572.115-99.572
TTM120.7772.093+118.684
YOY35.7922.884+32.908
5Y35.4973.542+31.955
10Y19.6083.916+15.692
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Achieve Life Sciences Inc.

3.1. Institutions holding Achieve Life Sciences Inc

Institutions are holding 26.481% of the shares of Achieve Life Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Shay Capital LLC3.42530.5971725000-16000-2.1592
2023-12-31Vanguard Group Inc2.86170.0001605710117571.9794
2023-12-31Long Focus Capital Management, LLC1.17220.03424809900
2023-12-31Geode Capital Management, LLC0.87370.000118492500
2023-12-31LPL Financial Corp0.84330.0005178500140008.5106
2023-12-31Raymond James & Associates0.73150.000515482987295.9747
2023-12-31Northern Trust Corp0.48180.00011019842302729.164
2023-12-31Walleye Trading Advisors, LLC0.39020.0007825991294018.5762
2023-12-31Wells Fargo & Co0.33020.000169891-51090-42.2298
2023-12-31J. Goldman & Co LP0.31890.011367501675010
2023-12-31State Street Corporation0.299106331600
2023-12-31Advisor Group Holdings, Inc.0.28280.00045985249000451.5297
2023-12-31BlackRock Inc0.2477052431-154-0.2929
2023-12-31Squarepoint Ops LLC0.10920.0002231051063185.2253
2023-12-31Manchester Financial Inc0.09020.022191005002.6882
2023-12-31Diametric Capital, LP0.08860.04718753-60457-76.325
2023-12-31Group One Trading, LP0.06010.000112715268526.7697
2023-12-31SIMPLEX TRADING, LLC0.0546011560110752283.5052
2023-12-31Bank of New York Mellon Corp0.054101144100
2023-12-31Renaissance Technologies Corp0.05150.000110900-11200-50.6787
Total 12.76670.71432702211+72944+2.7%

3.2. Funds holding Achieve Life Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.84460.000263182100
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.72950.00124986690263.7477
2024-02-29Fidelity Extended Market Index0.33730.0012115547-560-0.4823
2023-09-30BlackRock Extended Mkt Composite0.14860.00165090500
2024-03-31BlackRock Extended Equity Market K0.12970.001444426160.036
2024-02-29Fidelity Total Market Index0.08890.00013045100
2024-02-29Fidelity Series Total Market Index0.08040.00022755300
2024-02-29Vanguard Balanced Index Inv0.0590.00022020000
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05440.00131862200
2023-12-31Northern Trust Extended Eq Market Idx0.05440.00131862200
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.05240.00121793600
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.04910.00021680700
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.04910.000316807-213755-92.7104
2023-12-31SSgA U.S. Extended Market Index Class I0.04470.00231530300
2023-12-31Northern Small Cap Core K0.04290.01311470000
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04210.001214405270.1878
2024-02-29Fidelity Nasdaq Composite Index0.03020.00031035800
2024-02-29Spartan Total Market Index Pool E0.02570.0001878900
2024-02-29Schwab Total Stock Market Index0.02420.0002827900
2024-02-29Vanguard U.S. Eq Idx £ Acc0.02380.0002814400
Total 3.9110.02761339541-205246-15.3%

3.3. Insider Transactions

Insiders are holding 9.282% of the shares of Achieve Life Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-05-30John BencichBUY50005.5

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Achieve Life Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.160-0.071-56%-0.144-10%-0.025-84%-0.028-82%
Book Value Per Share---0.0420.093-145%0.321-113%0.483-109%0.584-107%
Current Ratio--0.8163.690-78%5.684-86%6.603-88%5.146-84%
Debt To Asset Ratio--1.0750.888+21%0.691+56%0.417+158%0.357+201%
Debt To Equity Ratio---13.239-100%6.702-100%4.123-100%2.298-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.160-0.218+36%-0.309+93%-0.199+25%-0.163+2%
Free Cash Flow Per Share---0.128-0.179+40%-0.274+115%-0.176+38%-0.143+12%
Free Cash Flow To Equity Per Share---0.128-0.067-47%-0.133+4%0.009-1569%-0.004-97%
Gross Profit Margin--1.0101.003+1%1.000+1%1.001+1%1.000+1%
Intrinsic Value_10Y_max---3.384--------
Intrinsic Value_10Y_min---9.269--------
Intrinsic Value_1Y_max---0.541--------
Intrinsic Value_1Y_min---0.903--------
Intrinsic Value_3Y_max---1.471--------
Intrinsic Value_3Y_min---2.751--------
Intrinsic Value_5Y_max---2.216--------
Intrinsic Value_5Y_min---4.627--------
Market Cap154133550.000+8%141117828.000174770319.750-19%155846145.000-9%171317385.711-18%123888437.262+14%
Net Profit Margin----0%-0%-0%-0.4080%
Operating Margin----0%-0%-0%-0.4260%
Operating Ratio----0%-0%-0%0.672-100%
Pb Ratio-106.446-9%-97.457120.777-181%35.792-372%35.497-375%19.608-597%
Pe Ratio-7.037-9%-6.443-5.873-9%-4.145-36%-6.491+1%-5.060-21%
Price Per Share4.500+8%4.1205.103-19%4.550-9%5.002-18%3.617+14%
Price To Free Cash Flow Ratio-8.818-9%-8.073-7.223-11%-4.742-41%-7.773-4%-6.907-14%
Price To Total Gains Ratio-28.096-9%-25.723-15.542-40%-14.304-44%-10.130-61%-12.518-51%
Quick Ratio--0.7523.458-78%5.439-86%6.352-88%5.302-86%
Return On Assets---0.283-0.330+17%-0.363+29%-0.267-6%-0.221-22%
Return On Equity----6.0500%-3.8760%-2.1460%-1.1930%
Total Gains Per Share---0.160-0.071-56%-0.144-10%-0.025-84%-0.028-82%
Usd Book Value---1448000.0003183000.000-145%10986500.000-113%16536500.000-109%20002150.000-107%
Usd Book Value Change Per Share---0.160-0.071-56%-0.144-10%-0.025-84%-0.028-82%
Usd Book Value Per Share---0.0420.093-145%0.321-113%0.483-109%0.584-107%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.160-0.218+36%-0.309+93%-0.199+25%-0.163+2%
Usd Free Cash Flow---4370000.000-6125000.000+40%-9387250.000+115%-6012450.000+38%-4914500.000+12%
Usd Free Cash Flow Per Share---0.128-0.179+40%-0.274+115%-0.176+38%-0.143+12%
Usd Free Cash Flow To Equity Per Share---0.128-0.067-47%-0.133+4%0.009-1569%-0.004-97%
Usd Market Cap154133550.000+8%141117828.000174770319.750-19%155846145.000-9%171317385.711-18%123888437.262+14%
Usd Price Per Share4.500+8%4.1205.103-19%4.550-9%5.002-18%3.617+14%
Usd Profit---5476000.000-7597000.000+39%-10835000.000+98%-6900250.000+26%-5758450.000+5%
Usd Revenue----0%-0%-0%1511550.000-100%
Usd Total Gains Per Share---0.160-0.071-56%-0.144-10%-0.025-84%-0.028-82%
 EOD+6 -2MRQTTM+13 -16YOY+15 -145Y+11 -1810Y+15 -16

4.2. Fundamental Score

Let's check the fundamental score of Achieve Life Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.037
Price to Book Ratio (EOD)Between0-1-106.446
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.752
Current Ratio (MRQ)Greater than10.816
Debt to Asset Ratio (MRQ)Less than11.075
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.283
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Achieve Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.618
Ma 20Greater thanMa 504.477
Ma 50Greater thanMa 1004.420
Ma 100Greater thanMa 2004.439
OpenGreater thanClose4.420
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Stockholder Equity 8,303-7,8604439,2569,699-5,6614,038-5,486-1,448
Net Debt  -8,5738,542-31-9,211-9,2425,651-3,5914,7761,185
Long-term Assets Other  2,559-2,49168-19492574-1,242-1,168



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets19,371
Total Liabilities20,819
Total Stockholder Equity-1,448
 As reported
Total Liabilities 20,819
Total Stockholder Equity+ -1,448
Total Assets = 19,371

Assets

Total Assets19,371
Total Current Assets16,982
Long-term Assets2,389
Total Current Assets
Cash And Cash Equivalents 15,546
Net Receivables 111
Other Current Assets 1,325
Total Current Assets  (as reported)16,982
Total Current Assets  (calculated)16,982
+/-0
Long-term Assets
Property Plant Equipment 79
Goodwill 1,034
Intangible Assets 1,197
Other Assets 0
Long-term Assets  (as reported)2,389
Long-term Assets  (calculated)2,310
+/- 79

Liabilities & Shareholders' Equity

Total Current Liabilities20,813
Long-term Liabilities6
Total Stockholder Equity-1,448
Total Current Liabilities
Short-term Debt 16,725
Short Long Term Debt 16,662
Accounts payable 618
Other Current Liabilities 3,470
Total Current Liabilities  (as reported)20,813
Total Current Liabilities  (calculated)37,475
+/- 16,662
Long-term Liabilities
Long-term Liabilities  (as reported)6
Long-term Liabilities  (calculated)0
+/- 6
Total Stockholder Equity
Common Stock90
Retained Earnings -165,751
Accumulated Other Comprehensive Income 4
Other Stockholders Equity 164,209
Total Stockholder Equity (as reported)-1,448
Total Stockholder Equity (calculated)-1,448
+/-0
Other
Capital Stock90
Cash and Short Term Investments 15,546
Common Stock Shares Outstanding 21,166
Liabilities and Stockholders Equity 19,371
Net Debt 1,185
Net Invested Capital 15,214
Net Working Capital -3,831
Property Plant and Equipment Gross 66
Short Long Term Debt Total 16,731



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-31
> Total Assets 
0
0
0
3,200
0
0
2,200
19,600
15,700
20,500
23,500
26,800
27,200
28,500
27,800
28,900
26,000
23,600
22,200
18,800
17,200
14,400
16,300
18,100
16,318
18,348
16,260
14,310
13,729
12,798
17,179
15,864
26,283
23,800
20,944
17,934
15,631
12,980
23,892
21,468
18,667
30,505
26,838
22,571
16,841
12,852
24,744
57,914
53,146
78,087
72,107
68,493
59,958
52,640
48,325
45,249
39,387
33,434
20,248
14,790
11,097
7,383
14,584
68,980
56,438
51,142
47,773
89,918
84,597
79,525
74,680
68,015
115,221
108,017
97,172
82,016
75,354
69,308
61,639
55,689
49,824
49,732
62,651
56,291
46,384
63,356
68,237
58,209
48,841
42,198
35,074
27,470
17,903
14,878
13,029
9,892
8,460
19,220
17,141
19,084
14,501
14,755
11,492
21,078
16,647
16,458
27,617
40,298
33,662
45,565
37,799
47,516
40,614
33,985
23,723
29,971
20,798
28,915
24,337
19,371
19,37124,33728,91520,79829,97123,72333,98540,61447,51637,79945,56533,66240,29827,61716,45816,64721,07811,49214,75514,50119,08417,14119,2208,4609,89213,02914,87817,90327,47035,07442,19848,84158,20968,23763,35646,38456,29162,65149,73249,82455,68961,63969,30875,35482,01697,172108,017115,22168,01574,68079,52584,59789,91847,77351,14256,43868,98014,5847,38311,09714,79020,24833,43439,38745,24948,32552,64059,95868,49372,10778,08753,14657,91424,74412,85216,84122,57126,83830,50518,66721,46823,89212,98015,63117,93420,94423,80026,28315,86417,17912,79813,72914,31016,26018,34816,31818,10016,30014,40017,20018,80022,20023,60026,00028,90027,80028,50027,20026,80023,50020,50015,70019,6002,200003,200000
   > Total Current Assets 
0
0
0
1,900
0
0
500
18,400
14,600
19,200
22,400
25,500
26,000
27,100
26,200
27,200
24,200
21,900
20,600
17,400
16,000
13,300
15,300
17,200
15,567
17,698
15,695
13,808
13,288
12,426
16,797
15,467
25,451
22,505
19,540
16,624
14,167
11,493
22,325
19,862
17,122
28,978
25,263
21,039
15,423
11,563
23,585
56,716
52,033
76,889
70,787
66,846
58,409
50,874
46,533
35,232
29,610
23,949
19,682
14,249
10,539
6,683
13,991
68,399
55,849
50,560
47,194
89,318
83,916
78,809
73,973
67,326
114,551
104,888
95,817
80,179
74,917
67,587
59,707
53,867
48,149
47,853
61,315
55,262
45,506
62,747
67,597
57,570
47,985
41,380
34,296
27,199
17,452
14,464
8,626
5,908
4,746
15,572
13,519
15,537
10,531
10,802
7,639
17,384
12,902
12,656
24,112
36,975
30,439
42,431
34,733
44,594
37,692
31,148
20,957
24,837
18,224
26,478
21,897
16,982
16,98221,89726,47818,22424,83720,95731,14837,69244,59434,73342,43130,43936,97524,11212,65612,90217,3847,63910,80210,53115,53713,51915,5724,7465,9088,62614,46417,45227,19934,29641,38047,98557,57067,59762,74745,50655,26261,31547,85348,14953,86759,70767,58774,91780,17995,817104,888114,55167,32673,97378,80983,91689,31847,19450,56055,84968,39913,9916,68310,53914,24919,68223,94929,61035,23246,53350,87458,40966,84670,78776,88952,03356,71623,58511,56315,42321,03925,26328,97817,12219,86222,32511,49314,16716,62419,54022,50525,45115,46716,79712,42613,28813,80815,69517,69815,56717,20015,30013,30016,00017,40020,60021,90024,20027,20026,20027,10026,00025,50022,40019,20014,60018,400500001,900000
       Cash And Cash Equivalents 
0
0
0
0
0
0
400
5,700
5,000
9,400
5,900
7,200
5,700
6,400
7,300
5,300
5,200
7,000
6,600
17,000
4,700
5,400
7,700
16,800
7,342
7,850
6,063
6,697
7,142
4,708
3,470
455
2,928
22,108
425
378
3,367
11,271
22,149
1,709
16,899
28,728
1,712
417
3,866
2,840
22,548
49,318
48,226
67,049
44,190
35,772
15,757
2,545
2,288
6,535
17,597
5,728
6,048
7,618
9,393
4,196
10,053
62,051
45,475
33,011
11,781
23,533
6,998
20,876
15,723
28,517
56,852
13,842
11,362
18,075
18,628
18,749
12,950
14,593
28,630
40,614
48,950
27,897
25,278
48,001
42,477
34,310
18,913
10,581
11,800
15,233
15,690
13,916
8,021
5,284
4,165
15,280
11,755
9,515
7,320
10,446
7,375
16,664
12,156
12,111
22,393
35,853
29,637
42,001
33,312
43,022
36,337
29,378
18,197
24,771
16,514
25,071
19,869
15,546
15,54619,86925,07116,51424,77118,19729,37836,33743,02233,31242,00129,63735,85322,39312,11112,15616,6647,37510,4467,3209,51511,75515,2804,1655,2848,02113,91615,69015,23311,80010,58118,91334,31042,47748,00125,27827,89748,95040,61428,63014,59312,95018,74918,62818,07511,36213,84256,85228,51715,72320,8766,99823,53311,78133,01145,47562,05110,0534,1969,3937,6186,0485,72817,5976,5352,2882,54515,75735,77244,19067,04948,22649,31822,5482,8403,8664171,71228,72816,8991,70922,14911,2713,36737842522,1082,9284553,4704,7087,1426,6976,0637,8507,34216,8007,7005,4004,70017,0006,6007,0005,2005,3007,3006,4005,7007,2005,9009,4005,0005,700400000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
16,100
17,900
20,000
20,300
18,600
21,300
18,500
14,500
13,700
0
0
0
7,500
10,900
7,924
9,494
9,223
6,766
5,772
7,302
12,959
14,669
22,177
21,800
18,821
15,956
10,528
11,271
14,500
17,955
17,955
28,728
23,290
20,164
11,273
8,537
895
0
0
0
16,686
22,506
33,232
41,706
38,377
27,664
11,215
17,532
11,130
5,891
376
1,882
2,420
2,517
2,111
14,293
30,286
61,574
74,100
54,536
53,533
36,410
54,469
83,806
73,711
57,308
45,961
38,243
33,827
24,629
8,922
0
5,057
19,160
15,091
12,185
23,460
20,876
27,201
29,147
20,655
10,230
760
0
0
222
222
0
1,390
5,089
2,345
0
0
50
0
0
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000500050002,3455,0891,39002222220076010,23020,65529,14727,20120,87623,46012,18515,09119,1605,05708,92224,62933,82738,24345,96157,30873,71183,80654,46936,41053,53354,53674,10061,57430,28614,2932,1112,5172,4201,8823765,89111,13017,53211,21527,66438,37741,70633,23222,50616,6860008958,53711,27320,16423,29028,72817,95517,95514,50011,27110,52815,95618,82121,80022,17714,66912,9597,3025,7726,7669,2239,4947,92410,9007,50000013,70014,50018,50021,30018,60020,30020,00017,90016,1000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,057
3,474
9,688
9,672
8,044
8,172
5,549
4,577
456
182
234
1,375
153
139
30
31
3,109
2,823
413
3,595
1,224
1,348
1,498
987
812
774
956
1,138
1,041
5,477
6,739
10,217
8,875
8,776
4,951
4,846
5,789
1,630
225
61
125
53
47
36
510
237
241
70
9
7
124
25
7
7
0
0
8
8
0
0
0
0
0
151
153
0
313
145
105
89
350
83
111
1118335089105145313015315100000880077251247970241237510364753125612251,6305,7894,8464,9518,7768,87510,2176,7395,4771,0411,1389567748129871,4981,3481,2243,5954132,8233,10931301391531,3752341824564,5775,5498,1728,0449,6729,6883,4747,0570000000000000000000000005,0000000000000000000000000
       Other Current Assets 
0
0
0
1,900
0
0
100
12,700
9,600
9,800
16,500
18,300
20,300
20,700
18,900
21,900
19,000
14,900
14,000
400
11,300
7,900
100
400
302
354
408
346
374
416
368
343
346
397
294
290
271
222
176
199
223
250
261
459
284
186
142
342
333
152
239
524
1,249
1,073
1,291
577
616
455
546
587
631
575
734
722
5,440
2,843
1,532
2,987
1,470
1,899
3,730
1,587
2,456
6,284
9,606
3,755
4,537
3,542
2,713
5,770
1,821
2,288
2,462
2,165
499
304
1,599
1,987
233
307
158
954
765
307
535
393
574
168
349
926
866
356
264
670
746
545
1,669
1,122
802
430
1,270
1,419
1,355
1,457
2,615
2,454
1,621
1,308
1,895
1,325
1,3251,8951,3081,6212,4542,6151,4571,3551,4191,2704308021,1221,6695457466702643568669263491685743935353077659541583072331,9871,5993044992,1652,4622,2881,8215,7702,7133,5424,5373,7559,6066,2842,4561,5873,7301,8991,4702,9871,5322,8435,4407227345756315875464556165771,2911,0731,2495242391523333421421862844592612502231991762222712902943973463433684163743464083543024001007,90011,30040014,00014,90019,00021,90018,90020,70020,30018,30016,5009,8009,60012,700100001,900000
   > Long-term Assets 
0
0
0
1,300
0
0
1,700
1,200
1,100
1,300
1,100
1,300
1,200
1,400
1,600
1,700
1,800
1,700
1,600
1,400
1,200
1,100
1,000
900
751
650
565
502
441
373
382
397
832
1,296
1,404
1,310
1,464
1,487
1,567
1,606
1,545
1,528
1,575
1,531
1,417
1,289
1,160
1,198
1,113
1,198
1,320
1,647
1,549
1,766
1,792
10,017
9,777
9,485
566
541
558
700
593
581
589
582
579
600
681
716
707
689
670
3,129
1,355
1,837
437
1,721
1,932
1,822
1,675
1,879
1,336
1,029
878
609
640
639
856
818
778
271
451
414
4,403
3,984
3,714
3,648
3,622
3,547
3,970
3,953
3,853
3,694
3,745
3,802
3,505
3,323
3,223
3,134
3,066
2,922
2,922
2,837
2,766
5,134
2,574
2,437
2,440
2,389
2,3892,4402,4372,5745,1342,7662,8372,9222,9223,0663,1343,2233,3233,5053,8023,7453,6943,8533,9533,9703,5473,6223,6483,7143,9844,4034144512717788188566396406098781,0291,3361,8791,6751,8221,9321,7214371,8371,3553,1296706897077166816005795825895815937005585415669,4859,77710,0171,7921,7661,5491,6471,3201,1981,1131,1981,1601,2891,4171,5311,5751,5281,5451,6061,5671,4871,4641,3101,4041,2968323973823734415025656507519001,0001,1001,2001,4001,6001,7001,8001,7001,6001,4001,2001,3001,1001,3001,1001,2001,700001,300000
       Property Plant Equipment 
0
0
0
1,200
0
0
1,200
1,100
1,100
1,200
1,100
1,200
1,200
1,400
1,600
1,700
1,700
1,700
1,500
1,400
1,300
1,100
1,000
900
751
650
565
502
441
373
382
397
832
1,296
1,404
1,310
1,464
1,487
1,567
1,606
1,545
1,528
1,523
1,480
1,366
1,238
1,108
1,006
930
1,109
1,240
1,186
1,096
1,321
1,352
9,578
9,777
8,988
58
44
61
98
84
72
80
73
70
87
171
207
198
180
161
226
223
371
437
1,721
443
397
349
354
312
1,029
416
406
380
639
546
534
493
271
166
129
94
59
18
42
32
35
535
485
436
573
337
296
551
188
380
121
100
79
49
33
18
123
109
95
80
79
798095109123183349791001213801885512963375734364855353532421859941291662714935345466393804064161,0293123543493974431,721437371223226161180198207171877073807284986144588,9889,7779,5781,3521,3211,0961,1861,2401,1099301,0061,1081,2381,3661,4801,5231,5281,5451,6061,5671,4871,4641,3101,4041,2968323973823734415025656507519001,0001,1001,3001,4001,5001,7001,7001,7001,6001,4001,2001,2001,1001,2001,1001,1001,200001,200000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-5,894
-5,894
-5,894
-5,894
-5,894
0
0
0
-5,894
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,034
0
0
0
1,034
0
0
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,034001,0340001,0340000000000000000000-5,894000-5,894-5,894-5,894-5,894-5,89400000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
280
280
280
280
280
0
0
0
280
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,977
0
0
0
2,755
0
0
2,588
2,532
2,477
2,421
2,365
2,310
2,254
2,199
2,143
2,087
2,031
1,976
1,920
1,864
1,809
1,752
1,697
1,641
1,586
1,530
1,475
1,418
1,363
1,308
1,252
1,197
1,1971,2521,3081,3631,4181,4751,5301,5861,6411,6971,7521,8091,8641,9201,9762,0312,0872,1432,1992,2542,3102,3652,4212,4772,5322,588002,7550002,977000000000000000000028000028028028028028000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,175
1,111
1,075
1,274
773
273
272
13
38
37
38
12
13
0
13
13
4,309
3,925
185
151
191
168
147
235
240
237
343
496
358
237
239
227
235
183
253
240
239
0
0
0
0
0
000002392402531832352272392373584963432372402351471681911511853,9254,309131301312383738132722737731,2741,0751,1111,175000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
12,200
0
0
14,000
8,700
9,400
9,200
9,300
10,000
8,900
9,600
9,900
10,400
10,700
11,300
12,000
11,300
11,100
9,300
9,200
8,100
7,843
7,812
7,883
5,800
5,925
2,248
1,051
1,199
1,452
2,433
2,826
2,210
2,141
2,573
2,744
2,159
1,998
2,569
2,413
3,493
2,497
2,478
5,690
22,650
22,489
23,081
22,927
25,451
19,627
17,325
18,739
13,345
11,286
8,917
4,768
4,083
2,702
3,445
3,576
46,021
36,169
30,243
33,470
45,793
43,099
44,327
34,655
37,125
37,094
33,302
27,411
15,809
15,089
16,623
18,096
18,478
20,220
23,267
23,800
22,232
16,365
35,165
29,465
20,769
14,625
13,949
10,655
8,504
2,012
1,775
2,347
2,013
2,318
2,778
2,977
3,282
4,312
3,251
3,351
3,028
1,662
1,920
1,942
3,012
3,574
4,711
3,099
19,474
19,181
20,819
22,679
21,668
20,355
19,216
20,299
20,819
20,81920,29919,21620,35521,66822,67920,81919,18119,4743,0994,7113,5743,0121,9421,9201,6623,0283,3513,2514,3123,2822,9772,7782,3182,0132,3471,7752,0128,50410,65513,94914,62520,76929,46535,16516,36522,23223,80023,26720,22018,47818,09616,62315,08915,80927,41133,30237,09437,12534,65544,32743,09945,79333,47030,24336,16946,0213,5763,4452,7024,0834,7688,91711,28613,34518,73917,32519,62725,45122,92723,08122,48922,6505,6902,4782,4973,4932,4132,5691,9982,1592,7442,5732,1412,2102,8262,4331,4521,1991,0512,2485,9255,8007,8837,8127,8438,1009,2009,30011,10011,30012,00011,30010,70010,4009,9009,6008,90010,0009,3009,2009,4008,70014,0000012,200000
   > Total Current Liabilities 
0
0
0
8,800
0
0
10,600
8,200
9,000
8,700
9,000
9,600
8,700
9,500
9,800
9,500
9,200
9,400
9,900
9,300
9,000
9,300
9,200
8,000
7,843
7,812
7,883
5,800
5,925
2,248
1,051
1,199
1,346
2,159
2,518
1,938
1,906
2,375
2,584
2,038
1,917
2,514
2,364
3,255
2,281
2,286
5,520
11,242
12,491
14,492
15,924
19,910
15,473
14,557
18,739
6,369
4,433
2,158
3,605
2,884
1,483
2,190
2,308
25,781
18,131
12,945
13,467
27,476
25,612
27,855
19,119
30,786
30,952
27,362
21,673
11,556
11,001
12,716
14,368
14,934
16,900
20,171
20,927
22,218
16,237
35,035
29,348
20,664
14,533
13,865
10,588
8,455
1,980
1,753
2,331
2,013
2,318
2,760
2,962
3,270
3,999
2,988
3,139
2,869
1,544
1,810
1,848
2,935
3,515
4,670
3,076
4,550
4,010
5,359
6,916
5,528
20,301
3,447
4,082
20,813
20,8134,0823,44720,3015,5286,9165,3594,0104,5503,0764,6703,5152,9351,8481,8101,5442,8693,1392,9883,9993,2702,9622,7602,3182,0132,3311,7531,9808,45510,58813,86514,53320,66429,34835,03516,23722,21820,92720,17116,90014,93414,36812,71611,00111,55621,67327,36230,95230,78619,11927,85525,61227,47613,46712,94518,13125,7812,3082,1901,4832,8843,6052,1584,4336,36918,73914,55715,47319,91015,92414,49212,49111,2425,5202,2862,2813,2552,3642,5141,9172,0382,5842,3751,9061,9382,5182,1591,3461,1991,0512,2485,9255,8007,8837,8127,8438,0009,2009,3009,0009,3009,9009,4009,2009,5009,8009,5008,7009,6009,0008,7009,0008,20010,600008,800000
       Short-term Debt 
0
0
0
3,200
0
0
4,100
5,200
5,000
5,200
5,200
5,200
5,200
5,200
5,200
5,100
5,100
5,100
5,100
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
0
19
75
134
138
141
144
148
151
155
143
111
78
45
26
27
27
28
29
22
15
8,047
0
0
0
0
903
905
632
361
717
457
1,328
1,307
1,278
1,344
1,314
1,305
1,384
1,406
1,417
1,429
1,440
1,451
1,084
1,088
1,089
1,090
1,092
1,097
1,106
1,114
236
52
54
53
52
51
57
57
57
55
46
31
27
0
11
11
11
186
192
198
203
196
165
129
92
67
68
69
69
59
41
23
58
16,429
60
61
16,725
16,725616016,42958234159696968679212916519620319819218611111102731465557575751525354522361,1141,1061,0971,0921,0901,0891,0881,0841,4511,4401,4291,4171,4061,3841,3051,3141,3441,2781,3071,32845771736163290590300008,047152229282727264578111143155151148144141138134751905,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,1005,1005,1005,1005,2005,2005,2005,2005,2005,2005,0005,2004,100003,200000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,486
0
0
0
683
0
0
0
829
850
46
31
27
0
0
0
0
170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,071
16,371
0
0
16,662
16,6620016,37116,0710000000000000017000002731468508290006830003,48600000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
900
0
0
2,600
1,400
1,800
1,100
2,300
2,200
2,100
2,400
3,000
2,600
2,300
2,600
3,200
3,000
2,900
3,500
4,000
2,800
2,622
2,663
2,766
800
925
0
0
1,199
1,327
2,084
2,384
1,801
1,765
2,231
2,436
1,887
1,762
2,371
2,253
3,177
2,236
2,259
5,493
5,668
368
1,577
1,259
2,372
1,847
1,912
2,923
1,462
1,429
152
2,700
0
0
0
0
0
0
0
0
893
1,166
1,643
1,465
3,217
2,877
2,883
5,718
7,050
7,925
130
39
139
923
1,341
1,562
72
988
302
1,779
1,343
592
559
1,043
2,121
359
233
495
213
420
251
458
144
694
707
574
859
184
523
326
332
585
575
815
841
418
656
412
1,660
1,063
361
638
618
6186383611,0631,6604126564188418155755853323265231848595747076941444582514202134952333592,1211,0435595921,3431,779302988721,5621,341923139391307,9257,0505,7182,8832,8773,2171,4651,6431,166893000000002,7001521,4291,4622,9231,9121,8472,3721,2591,5773685,6685,4932,2592,2363,1772,2532,3711,7621,8872,4362,2311,7651,8012,3842,0841,3271,199009258002,7662,6632,6222,8004,0003,5002,9003,0003,2002,6002,3002,6003,0002,4002,1002,2002,3001,1001,8001,4002,60000900000
       Other Current Liabilities 
0
0
0
4,700
0
0
3,900
1,600
2,200
2,400
1,500
2,200
1,400
1,900
1,600
1,800
1,800
1,700
1,600
1,300
1,100
800
200
200
221
149
117
0
-25
2,248
1,051
1
-46
41
-18
0
1,765
2,231
0
0
0
2,371
2,253
3,176,709
2,236
2,259
5,493
0
6,549
7,341
9,097
11,978
32
7,099
8,889
4,906
3,004
903
3,605
2,252
1,122
1,473
1,851
14,453
6,824
1,667
2,123
15,269
13,141
14,828
9,119
7,881
13,617
11,990
12,528
10,472
9,913
1,087
548
214
935
3,494
3,975
6,252
3,787
16,901
16,475
14,229
11,791
2,221
350
232
180
114
3
1,773
1,898
11
11
3,115
170
2,089
2,367
1,807
1,164
1,122
1,393
2,511
2,863
4,027
2,192
3,640
3,533
4,662
6,481
3,810
2,809
3,026
3,383
3,470
3,4703,3833,0262,8093,8106,4814,6623,5333,6402,1924,0272,8632,5111,3931,1221,1641,8072,3672,0891703,11511111,8981,77331141802323502,22111,79114,22916,47516,9013,7876,2523,9753,4949352145481,0879,91310,47212,52811,99013,6177,8819,11914,82813,14115,2692,1231,6676,82414,4531,8511,4731,1222,2523,6059033,0044,9068,8897,0993211,9789,0977,3416,54905,4932,2592,2363,176,7092,2532,3710002,2311,7650-1841-4611,0512,248-2501171492212002008001,1001,3001,6001,7001,8001,8001,6001,9001,4002,2001,5002,4002,2001,6003,900004,700000
   > Long-term Liabilities 
0
0
0
3,400
0
0
3,400
500
400
500
300
400
200
100
100
900
1,500
1,900
2,100
2,000
2,100
8,500
9,000
100
7,600
7,700
7,766
5,800
5,925
0
0
1,199
107
274
308
272
235
198
160
121
81
55
49
238
216
193
170
11,408
9,999
8,589
7,002
5,541
4,154
2,768
9,850
6,976
6,852
6,759
1,163
1,199
1,219
1,255
1,268
20,240
18,038
17,298
20,003
18,317
17,487
16,472
15,536
6,339
6,142
5,940
5,738
4,253
4,088
3,907
3,728
3,544
3,320
3,096
2,873
14
128
130
117
105
92
84
67
49
32
22
16
240
420
18
15
12
313
263
212
159
118
110
94
77
59
41
23
14,924
15,171
15,460
15,763
16,140
54
15,769
16,217
6
616,21715,7695416,14015,76315,46015,17114,924234159779411011815921226331312151842024016223249678492105117130128142,8733,0963,3203,5443,7283,9074,0884,2535,7385,9406,1426,33915,53616,47217,48718,31720,00317,29818,03820,2401,2681,2551,2191,1991,1636,7596,8526,9769,8502,7684,1545,5417,0028,5899,99911,4081701932162384955811211601982352723082741071,199005,9255,8007,7667,7007,6001009,0008,5002,1002,0002,1001,9001,5009001001002004003005004005003,400003,400000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,606
6,500
6,339
6,142
5,940
5,738
4,253
4,088
3,907
3,728
3,544
3,320
3,096
2,873
14
128
130
117
105
92
84
67
49
32
22
16
0
0
18
15
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001215180016223249678492105117130128142,8733,0963,3203,5443,7283,9074,0884,2535,7385,9406,1426,3396,5006,606000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
627
0
0
0
124
0
0
16
0
0
18
15
12
24
20
212
159
0
110
94
2
59
0
23
4
0
0
0
0
0
0
0
0
0000000042305929411001592122024121518001600124000627000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,866
9,036
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000009,0369,866000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-9,000
0
0
-11,800
10,900
6,300
11,300
14,200
16,800
18,300
18,900
17,900
18,500
15,300
12,300
10,200
7,500
6,100
5,100
7,100
10,000
8,475
10,536
8,377
8,509
7,804
10,551
16,128
14,665
24,831
21,368
18,118
15,724
13,490
10,406
21,149
19,310
16,669
27,936
24,425
19,077
14,344
10,373
19,054
35,264
30,657
55,006
49,181
43,042
40,331
35,315
29,586
31,904
28,101
24,516
15,480
10,707
8,395
3,938
11,008
22,959
20,269
20,899
14,303
44,125
41,498
35,198
40,025
30,890
78,127
74,715
69,761
66,207
60,265
52,685
43,543
37,211
29,604
26,465
38,851
34,059
30,019
28,191
38,772
37,440
34,216
28,249
24,419
18,966
15,891
13,103
10,682
7,879
6,142
16,442
14,164
15,802
10,189
11,504
8,141
18,050
14,985
14,538
25,675
37,286
30,088
40,854
34,700
28,042
21,433
13,166
1,044
8,303
443
9,699
4,038
-1,448
-1,4484,0389,6994438,3031,04413,16621,43328,04234,70040,85430,08837,28625,67514,53814,98518,0508,14111,50410,18915,80214,16416,4426,1427,87910,68213,10315,89118,96624,41928,24934,21637,44038,77228,19130,01934,05938,85126,46529,60437,21143,54352,68560,26566,20769,76174,71578,12730,89040,02535,19841,49844,12514,30320,89920,26922,95911,0083,9388,39510,70715,48024,51628,10131,90429,58635,31540,33143,04249,18155,00630,65735,26419,05410,37314,34419,07724,42527,93616,66919,31021,14910,40613,49015,72418,11821,36824,83114,66516,12810,5517,8048,5098,37710,5368,47510,0007,1005,1006,1007,50010,20012,30015,30018,50017,90018,90018,30016,80014,20011,3006,30010,900-11,80000-9,000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
34,300
34,300
34,300
34,500
34,700
34,900
34,900
35,000
35,000
35,000
35,000
37,100
37,100
37,100
37,714
37,720
37,727
38,077
38,097
42,590
42,627
43,302
55,953
55,986
55,990
56,011
56,062
56,073
69,319
70,085
71,019
86,088
86,177
86,202
86,234
86,344
103,917
123,444
124,144
153,425
153,896
154,781
155,304
156,264
156,323
156,705
157,015
157,248
6
6
6
6
6
6
6
6
6
10
10
10
10
10
15
14
15
15
15
15
15
15
15
15
21
22
22
24
30
29
30
29
30
29
30
30
11
12
13
15
16
18
18
19
19
41
43
51
74
76
76
79
79
79
79
79
79
87
87
90
90
90
9090908787797979797979767674514341191918181615131211303029302930293024222221151515151515151514151010101010666666666157,248157,015156,705156,323156,264155,304154,781153,896153,425124,144123,444103,91786,34486,23486,20286,17786,08871,01970,08569,31956,07356,06256,01155,99055,98655,95343,30242,62742,59038,09738,07737,72737,72037,71437,10037,10037,10035,00035,00035,00035,00034,90034,90034,70034,50034,30034,30034,3000000000000
   Retained Earnings Total Equity000-144,928-135,93600000-79,744-68,433-60,434-55,710-51,946-49,024-45,704-42,510-38,837-31,288-25,381-21,744-18,504-15,716-12,694-8,915-203,230-200,230-196,942-191,097-187,407-180,518-176,811-175,087-170,537-164,527-159,958-154,276-149,340-142,325-133,689-127,011-116,957-108,537-101,840-97,737-91,817-87,602-80,742-71,173-75,644000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-400
0
0
-700
-800
-900
-1,000
-200
0
0
0
0
0
0
0
0
0
0
0
0
0
-18
-18
-18
1
-341
-340
46
40
-32
16
32
26
15
7
3
4
8
-32
-20
-35
-24
-14
2
7
10
14
11
0
-9
-22
-2
1
3
-8
2,608
2,640
2,639
2,639
2,642
2,640
2,642
2,640
2,640
2,605
2,662
2,608
2,528
2,636
2,636
2,617
2,655
2,637
2,631
2,616
2,640
2,643
2,642
2,641
2,637
2,622
2,635
2,637
2,642
2,632
2,646
2,650
2,643
2,640
2,641
2,641
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
444444444444444444444555552,6412,6412,6402,6432,6502,6462,6322,6422,6372,6352,6222,6372,6412,6422,6432,6402,6162,6312,6372,6552,6172,6362,6362,5282,6082,6622,6052,6402,6402,6422,6402,6422,6392,6392,6402,608-831-2-22-9011141072-14-24-35-20-32843715263216-324046-340-3411-18-18-180000000000000-200-1,000-900-800-70000-400000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,224
108,660
108,986
163,078
163,901
164,828
165,395
166,156
167,011
167,899
168,242
169,272
173,149
190,469
191,373
191,889
196,067
211,187
211,590
212,058
212,977
212,843
213,239
213,450
213,662
19,581
20,556
21,840
34,926
35,887
41,161
41,455
50,318
50,628
63,709
63,962
66,429
81,307
97,640
98,441
120,515
0
0
0
0
0
144,148
145,280
0
0
0
000145,280144,14800000120,51598,44197,64081,30766,42963,96263,70950,62850,31841,45541,16135,88734,92621,84020,55619,581213,662213,450213,239212,843212,977212,058211,590211,187196,067191,889191,373190,469173,149169,272168,242167,899167,011166,156165,395164,828163,901163,078108,986108,660108,224000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
500
0
0
900
30,700
31,000
35,100
100
-100
0
0
-100
-100
0
0
-100
0
0
0
100
0
-8
54
-5
3,109
3,204
3,251
-19
3,765
3,731
3,868
-14
0
56,062
0
0
0
0
0
0
86,167,537
3
0
103,917
7,499
0
0
11
0
0
0
0
156,704,899
157,015
0
55,920
56,070
56,169
56,275
65,727
73,798
74,150
74,628
74,926
107,579
107,940
108,224
108,660
108,986
163,078
163,901
164,828
165,395
166,156
167,011
167,899
168,242
169,272
173,149
190,469
191,373
191,889
196,067
211,187
211,590
212,058
212,977
212,843
213,239
213,450
213,662
19,581
20,556
21,840
34,926
35,887
41,161
41,455
50,318
50,628
63,709
63,962
66,429
81,307
97,640
98,441
120,515
121,052
121,545
122,509
124,710
125,665
144,148
145,280
162,772
164,219
164,209
164,209164,219162,772145,280144,148125,665124,710122,509121,545121,052120,51598,44197,64081,30766,42963,96263,70950,62850,31841,45541,16135,88734,92621,84020,55619,581213,662213,450213,239212,843212,977212,058211,590211,187196,067191,889191,373190,469173,149169,272168,242167,899167,011166,156165,395164,828163,901163,078108,986108,660108,224107,940107,57974,92674,62874,15073,79865,72756,27556,16956,07055,9200157,015156,704,899000011007,499103,9170386,167,53700000056,0620-143,8683,7313,765-193,2513,2043,109-554-80100000-10000-100-10000-10010035,10031,00030,70090000500000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-228
Gross Profit-228-228
 
Operating Income (+$)
Gross Profit-228
Operating Expense-27,022
Operating Income-27,250-27,250
 
Operating Expense (+$)
Research Development15,814
Selling General Administrative11,412
Selling And Marketing Expenses0
Operating Expense27,02227,226
 
Net Interest Income (+$)
Interest Income735
Interest Expense-2,853
Other Finance Cost-240
Net Interest Income-1,878
 
Pretax Income (+$)
Operating Income-27,250
Net Interest Income-1,878
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-29,815-24,685
EBIT - interestExpense = -30,103
-29,815
-26,962
Interest Expense2,853
Earnings Before Interest and Taxes (EBIT)-27,250-26,962
Earnings Before Interest and Taxes (EBITDA)-27,022
 
After tax Income (+$)
Income Before Tax-29,815
Tax Provision-0
Net Income From Continuing Ops-35,571-29,815
Net Income-29,815
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses27,250
Total Other Income/Expenses Net-2,5651,878
 

Technical Analysis of Achieve Life Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Achieve Life Sciences Inc. The general trend of Achieve Life Sciences Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Achieve Life Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Achieve Life Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.6993 < 4.8 < 4.814.

The bearish price targets are: 4.2 > 4.02 > 3.82.

Tweet this
Achieve Life Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Achieve Life Sciences Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Achieve Life Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Achieve Life Sciences Inc. The current macd is 0.00185595.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Achieve Life Sciences Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Achieve Life Sciences Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Achieve Life Sciences Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Achieve Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartAchieve Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Achieve Life Sciences Inc. The current adx is 11.64.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Achieve Life Sciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Achieve Life Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Achieve Life Sciences Inc. The current sar is 4.05704904.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Achieve Life Sciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Achieve Life Sciences Inc. The current rsi is 51.62. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Achieve Life Sciences Inc Daily Relative Strength Index (RSI) ChartAchieve Life Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Achieve Life Sciences Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Achieve Life Sciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Achieve Life Sciences Inc Daily Stochastic Oscillator ChartAchieve Life Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Achieve Life Sciences Inc. The current cci is 12.58.

Achieve Life Sciences Inc Daily Commodity Channel Index (CCI) ChartAchieve Life Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Achieve Life Sciences Inc. The current cmo is 5.0293786.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Achieve Life Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartAchieve Life Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Achieve Life Sciences Inc. The current willr is -39.91588224.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Achieve Life Sciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Achieve Life Sciences Inc Daily Williams %R ChartAchieve Life Sciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Achieve Life Sciences Inc.

Achieve Life Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Achieve Life Sciences Inc. The current atr is 0.21888303.

Achieve Life Sciences Inc Daily Average True Range (ATR) ChartAchieve Life Sciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Achieve Life Sciences Inc. The current obv is 3,165,023.

Achieve Life Sciences Inc Daily On-Balance Volume (OBV) ChartAchieve Life Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Achieve Life Sciences Inc. The current mfi is 47.46.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Achieve Life Sciences Inc Daily Money Flow Index (MFI) ChartAchieve Life Sciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Achieve Life Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Achieve Life Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Achieve Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.618
Ma 20Greater thanMa 504.477
Ma 50Greater thanMa 1004.420
Ma 100Greater thanMa 2004.439
OpenGreater thanClose4.420
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Achieve Life Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Achieve Life Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Achieve Life Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Achieve Life Sciences Inc

I send you an email if I find something interesting about Achieve Life Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Achieve Life Sciences Inc.

Receive notifications about Achieve Life Sciences Inc in your mailbox!